Krystal Biotech, Inc. (KRYS) Revenue by Year
Krystal Biotech, Inc. generated $389.1M in revenue in fiscal year 2025. This represents an increase of 33.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $440.5M in revenue. The table below carries 10 fiscal years, from 2016 to 2025, and the quarters Krystal Biotech, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
KRYS Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
KRYS Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Krystal Biotech, Inc. financials
Frequently Asked Questions
What was Krystal Biotech, Inc.'s revenue in fiscal year 2025?
Krystal Biotech, Inc. generated $389.1M in revenue in fiscal year 2025.
How fast is Krystal Biotech, Inc.'s revenue growing?
Krystal Biotech, Inc. (KRYS) revenue rose by 33.9% year over year, from $290.5M to $389.1M in fiscal year 2025.
What is Krystal Biotech, Inc.'s revenue over the last twelve months?
Krystal Biotech, Inc. (KRYS) reported $440.5M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
What was Krystal Biotech, Inc.'s revenue in the most recent quarter?
Krystal Biotech, Inc. (KRYS) reported $119.2M in revenue in Q2 2026. This represents an increase of 24.1% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Krystal Biotech, Inc. (KRYS) reported on that line in every period on record.